Use of milrinone in the management of haemodynamic instability following duct ligation.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 20848128)

Published in Eur J Pediatr on September 17, 2010

Authors

Arvind Sehgal1, Johny V Francis, Anthony I Lewis

Author Affiliations

1: Monash Newborn, Monash Children's, Monash Medical Centre, Clayton, VIC, Australia. Arvind.Sehgal@southernhealth.org.au

Articles cited by this

Premature Infant Pain Profile: development and initial validation. Clin J Pain (1996) 3.37

Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation (2003) 2.67

Pilot study of milrinone for low systemic blood flow in very preterm infants. J Pediatr (2006) 2.22

Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med (1978) 2.03

Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. J Pediatr (2007) 1.81

Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2002) 1.51

Patent ductus arteriosus ligation and post-operative hemodynamic instability: case report and framework for enhanced neonatal care. Indian J Pediatr (2010) 1.44

Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. J Thorac Cardiovasc Surg (2010) 1.20

Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med (1995) 1.18

Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr (2008) 1.12

Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest (1996) 1.04

The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology (1999) 1.00

Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch Dis Child Fetal Neonatal Ed (2006) 0.97

Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol (1981) 0.87

Acute hemodynamic decompensation following patent ductus arteriosus ligation in premature infants. J Invest Surg (2008) 0.85

Inotropic responses change during postnatal maturation in rabbit. Am J Physiol (1988) 0.85

Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. J Cardiovasc Pharmacol (1989) 0.85

Effect of milrinone on myocardial mechanical function and cyclic AMP content in the fetal rabbit. Pediatr Res (1987) 0.79

Amrinone: is it the inotrope of choice? J Cardiothorac Anesth (1989) 0.79

Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium. Pediatr Res (1992) 0.79

The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Circulation (1986) 0.78